Neonatal lupus erythematosus (NLE) is a rare autoimmune disease caused by the transplacental transfer of maternal autoantibodies, especially anti-Ro/SSA, anti-La/SSB, and anti-U1RNP. The objective of this study was to review the clinical, paraclinical, and therapeutic management of fifteen newborns admitted to a neonatal reanimation center at Children's Hospital A. Harouchi, Ibn Rochd University Hospital Centre. Results: Among these fifteen newborns, two categories were observed: the first category included eleven newborns of known lupus mothers in whom the electrocardiogram systematically requested came back normal. Skin lesions or biological abnormalities were found in some of these newborns, while others were completely asymptomatic. Simple clinical and paraclinical monitoring was performed, and the short-and long-term evolution was favorable. The second category included four newborns of mothers initially not known to have lupus but in whom the diagnosis of SLE was established after a maternal check-up because of neonatal bradycardia or suggestive skin lesions. In these four newborns, the systematic ECG revealed complete atrioventricular block in two and right bundle branch block in another. The cardiac ultrasound revealed cardiac malformations in three newborns. The systematic biological assessment showed abnormalities in two, and skin lesions were found in two newborns. In the cases of BAVc and BBD, the treatment consisted of pacemaker implantation, whereas simple monitoring was carried out in the newborn with cutaneous lesions. In conclusion, the clinical manifestations of NLE are varied; they may include temporary onset or irreversible symptoms such as congenital heart block (CHB), particularly third-degree heart block, which is the most serious complication of NLE because of its high morbidity and mortality rate and requires strict monitoring of all mothers with known lupus or with risk factors.